Kohjin Bio Co (TSE:177A) EBIT: 円370 Mil (TTM As of Mar. 2026)


TSE:177A Kohjin Bio Co Ltd TSE:177A
19 GF Score
Price 円957.00
! 3 Warning Signs
View Full Analysis

What is Kohjin Bio Co EBIT?

Kohjin Bio Co TSE:177A -2.15% 19 EBIT is 円370 Mil as of Mar. 2026. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

Kohjin Bio Co's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was 円77 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円370 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Kohjin Bio Co's annualized ROC % for the quarter that ended in Mar. 2026 was 2.13%. Kohjin Bio Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Kohjin Bio Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 8.06%.

Kohjin Bio Co  (TSE:177A) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Kohjin Bio Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=167.768 * ( 1 - 16.39% )/( (6325.128 + 6867.353)/ 2 )
=140.2708248/6596.2405
=2.13 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8843.105 - 215.105 - ( 2587.815 - max(0, 2335.227 - 4638.099+2587.815))
=6325.128

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8904.397 - 138.202 - ( 2486.185 - max(0, 2369.315 - 4268.157+2486.185))
=6867.353

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Kohjin Bio Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=154.794/( ( (3462.383 + max(1365.057, 0)) + (3798.198 + max(1068.172, 0)) )/ 2 )
=154.794/( ( 4827.44 + 4866.37 )/ 2 )
=154.794/4846.905
=3.19 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(789.089 + 877.582 + 383.613) - (215.105 + 0 + 470.122)
=1365.057

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(562.433 + 871.817 + 299.449) - (138.202 + 0 + 527.325)
=1068.172

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Kohjin Bio Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=370.315/4597.125
=8.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kohjin Bio Co EBIT Related Terms

Kohjin Bio Co EBIT Historical Data

* Premium members only.

The historical data trend for Kohjin Bio Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kohjin Bio Co EBIT Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
961.00 1,276.80 658.47 1,045.37 370.32

Kohjin Bio Co Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial 0.00 381.12 664.25 292.92 77.40

TSE:177A vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Kohjin Bio Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kohjin Bio Co EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kohjin Bio Co's EV-to-EBIT falls into.


TSE:177A
19GF Score
Kohjin Bio Co Ltd TSE:177A
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kohjin Bio Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円370 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円370 Mil mean?
Kohjin Bio Co (TSE:177A) has a EBIT of 円370 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Kohjin Bio Co.
Is Kohjin Bio Co's EBIT too high?
Kohjin Bio Co's current EBIT is 円370 Mil. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's EBIT compare to VRTX and REGN?
Kohjin Bio Co's EBIT of 円370 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Kohjin Bio Co. Kohjin Bio Co's current EBIT is 円370 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current EBIT of 円370 Mil. The current EBIT is 円370 Mil. Kohjin Bio Co's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current EBIT is 円370 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kohjin Bio Co Business Description

Address 5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score

Get the complete analysis for TSE:177A

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円957.00
Price